General Question for the Week of July 17, 2023


Does CMS require that the JW modifier be reported when billing for packaged drugs?


Currently, CMS is not requiring the JW modifier when billing for packaged drugs, so the provider must consider using the same billing practice as with payable drugs or only report one charge line that reports the billing units associated only with the amount of drug administered.

Print Friendly, PDF & Email

CPT® copyright 2022 American Medical Association (AMA). All rights reserved.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

CPT is a registered trademark of the American Medical Association.